A 45-year-old with T2DM and ASCVD on metformin and basal insulin seeks CV risk reduction. Which agent class provides additional CV benefit?...

Question

A 45-year-old with T2DM and ASCVD on metformin and basal insulin seeks CV risk reduction. Which agent class provides additional CV benefit?

Accepted Answer

SGLT2 inhibitor or GLP-1 RA with CV benefit

Answer

DPP-4 inhibitor

Answer

Sulfonylurea

Answer

Thiazolidinedione

Answer

Meglitinide

us-abim MCQ (SBA): Type 2 Diabetes CV Risk